July 2026 Research Update

This month added clearer agreement on how cold agglutinin disease (CAD) should be confirmed in the lab, with the goal of making results more consistent across hospitals. A group of hematology and transfusion experts reached consensus on a set of diagnostic statements that highlight key test findings and the importance of handling blood samples at body temperature to prevent testing problems. The overall message is not that CAD diagnosis changed, but that the steps to get there can be standardized so fewer patients face delays or conflicting lab interpretations. [1]

In this consensus work, the experts agreed on 37 diagnostic statements across several parts of the testing process, including what to look for in immune-related blood bank testing and how to manage samples before they are analyzed. They emphasized a pattern that includes C3d positivity on the direct antiglobulin test (a blood test that checks for immune coating on red blood cells) and detection of cold agglutinins in the serum, along with keeping samples at 37C to avoid cold-related artifacts. For patients, this supports the idea that some uncertainty in early testing can come from how samples are handled, not only from the disease itself. [1]

For patients and caregivers, this mainly matters as a step toward more reliable diagnosis and fewer confusing lab results when CAD is being worked up or re-checked. This is expert consensus rather than a clinical trial, so it does not prove that outcomes improve, but it does clarify what many labs are aiming to measure and why warm sample handling is repeatedly stressed. What remains uncertain is how quickly different centers will adopt the same approach and whether it will measurably shorten time to diagnosis in real-world practice. [1]

This month, the new clinical information came from case reports showing that CAD can create very specific challenges during specialized procedures, but teams can sometimes work around them. Across these reports, the shared picture is that problems may arise during blood-handling circuits or temperature-sensitive steps, and adjustments to procedure choice or warming strategies were linked with successful completion in those individual patients. Because these are single-patient experiences, they are best read as examples of what can happen and how a team responded, not as proof that a specific approach will work for everyone. [2] [3]

One report described a patient with CAD and bullous pemphigoid who developed circuit clotting during selective plasma exchange. The clotting resolved after the team switched the procedure to double filtration plasmapheresis, suggesting that the specific type of plasma exchange circuit and filtration approach can matter when complications occur. For patients, this highlights that if a procedure runs into technical problems, teams may have alternate ways to deliver plasma-based treatments. [2]

A separate report described a man with CAD and IgA-kappa multiple myeloma who underwent autologous stem cell transplantation using a detailed temperature-management plan across stem cell mobilization, collection, processing, and infusion. The team reported successful stem cell collection and engraftment without cold-related complications, alongside use of sutimlimab (a complement inhibitor) around the procedure and active warming of the environment and equipment. In plain terms, this case shows that even when cold-triggered red cell clumping is a concern, carefully controlled temperature steps may allow complex treatments to proceed in selected situations. [3]

For patients, these reports mainly add to shared understanding of what CAD can complicate during procedures that move blood through tubing, filters, or collection devices. The information may matter now for awareness and planning conversations, but it is not strong enough to predict what will happen for another person because each report describes only 1 patient. What remains uncertain is how often these issues occur and which specific procedural adjustments work best across different centers and different CAD patterns. [2] [3]